Preventing And Treating Significant Infections In The Community And In Hospitals
Funder
National Health and Medical Research Council
Funding Amount
$328,990.00
Summary
Infections that require hospitalisation are common and a significant event for patients. This research will look at severe influenza and define how protective the influenza vaccination is against hospitalisation. It will also look at preventing healthcare associated infections and in particular those involving antibiotic resistant "superbugs".
Causes, Consequences And Costs Of Injury-related Hospitalisations For People With Dementia: Identifying Opportunities For Prevention And Enhanced Management
Funder
National Health and Medical Research Council
Funding Amount
$320,891.00
Summary
People with dementia have higher hospitalisation rates and poorer health outcomes than those of similar age without dementia. Injury is the most common cause of hospitalisation for people with dementia, however little is known about the hospitalisation experience for people with dementia who have an injury. This research will explore the influence of dementia on hospital admissions, clinical care, health outcomes and economic costs of older people with an injury to inform policy and practice.
Assessing The Benefit Of Low Dose Aspirin In The Prevention Of Severe Sepsis.
Funder
National Health and Medical Research Council
Funding Amount
$391,880.00
Summary
Recent discoveries suggest that low doses of aspirin may save lives in patients with infection by limiting its severity. We will conduct a large-scale primary prevention study using daily low-dose aspirin to explore whether this widely used drug can safely prevent severe infection. This study is made possible by collaborative involvement in an existing Australian and USA funded study called ASPREE. Finding a treatment that helps prevent severe effects and outcomes of infection would be a major h ....Recent discoveries suggest that low doses of aspirin may save lives in patients with infection by limiting its severity. We will conduct a large-scale primary prevention study using daily low-dose aspirin to explore whether this widely used drug can safely prevent severe infection. This study is made possible by collaborative involvement in an existing Australian and USA funded study called ASPREE. Finding a treatment that helps prevent severe effects and outcomes of infection would be a major health advance.Read moreRead less
Communication Technologies For Supporting Patients With Multiple Morbidities Accessing Hospital Services
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
This program of research focuses on the integration of accessible remote communication technologies, including mobile devices, for helping to engage and support patients accessing hospital services. There is a specific focus on using contemporary accessible technologies to support and empower people who may have difficulty following recommendations for disease management and lifestyle behaviours to reduce their risk of severe negative health events that cause hospitalisation or death.
Risks Of Using A Central Venous Catheter For Haemodialysis In Australia And Opportunities For Improvement
Funder
National Health and Medical Research Council
Funding Amount
$132,743.00
Summary
Patients with permanent or temporary severe kidney failure require dialysis treatment to remain alive and well. Commonly this is performed using a catheter (plastic tube) inserted into a large vein of the body. The use of these catheters, while life saving, is prone to complications. By assessing health data from multiple sources, this project will provide an understanding of the frequency and risk factors for such complications, and improve the lives of patients requiring such treatment.
Born A Bit Early: Long-term Child Educational And Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$597,170.00
Summary
This will be a population level study covering all children born in New South Wales between 1994 and 2010. The size of the study population will be approximately 1.5 million children. The ratio of males to females will be approximately 1:1.
Are ‘potentially Preventable Hospitalisations’ A Valid Measure Of The Quality And Affordability Of Primary And Community Care In Australia?
Funder
National Health and Medical Research Council
Funding Amount
$397,264.00
Summary
This project will investigate the validity of ‘potentially preventable hospitalisations’ (PPH) as a measure of the quality and affordability of primary and community care in Australia. We will explore relationships between use of primary care services, hospital admissions for PPH diagnoses, and health outcomes and quantify the contributions of person-, geographic- and service-level factors to variations in PPH. We will make recommendations regarding the ongoing use of PPH measures to track the i ....This project will investigate the validity of ‘potentially preventable hospitalisations’ (PPH) as a measure of the quality and affordability of primary and community care in Australia. We will explore relationships between use of primary care services, hospital admissions for PPH diagnoses, and health outcomes and quantify the contributions of person-, geographic- and service-level factors to variations in PPH. We will make recommendations regarding the ongoing use of PPH measures to track the impacts of health reform in Australia.Read moreRead less
Prophylactic Antibiotics To Prevent Recurrent Lower Respiratory Tract Infections In Children With Neurological Impairment (PARROT) Study
Funder
National Health and Medical Research Council
Funding Amount
$1,210,224.00
Summary
We plan a randomised controlled trial to determine if 12 months of a type of antibiotics (compared to placebo) reduces hospitalisations in children with neurological impairment. Currently this group of children are recurrently hospitalised and some doctors use long term antibiotics but there is no high level evidence for this practice. The study will be undertaken in the UK and Australia and involve 474 children. The study will lead to better clinical care and inform guidelines.
Randomized Control Trial Of A Cancer Shared Care Model
Funder
National Health and Medical Research Council
Funding Amount
$242,400.00
Summary
Cancer care in Australia remains fragmented. Shared care has been seen as a potentially more effective way to manage patients with chronic and subacute diseases, by overcoming many of the difficulties which beset the traditional hospital-based model. These difficulties include poor communication between hospital-based and community-based carers, the high costs of hospital-based care and the loss of involvement of the primary care health professional in ongoing care. This project is a trial of a ....Cancer care in Australia remains fragmented. Shared care has been seen as a potentially more effective way to manage patients with chronic and subacute diseases, by overcoming many of the difficulties which beset the traditional hospital-based model. These difficulties include poor communication between hospital-based and community-based carers, the high costs of hospital-based care and the loss of involvement of the primary care health professional in ongoing care. This project is a trial of a Shared Care Model (SCM) with cancer patients in a hospital in Western Australia. The project is designed to improve the emotional well-being and feelings of empowerment of the patients as well as reduce the number of unplanned admissions these patients need to make during their cancer treatment. The SCM intervention includes: -A patient-held record (PHR) comprising chemotherapy road map, treatment intention, medication list and communication pages for health workers; - Earlier and timely direct communication between specialist and general practitioner; -A Shared Care coordinator to assist with patient care and information; and - General practitioner educational and resource packages with tailored side effects table detailing anticipated side effects and actions to be taken. - For rural patients, the model can be expanded to include general practitioner administration of selected chemotherapeutic agents on alternate cycles. - Protocols for general practitioners administration of selected chemotherapeutic agents.Read moreRead less
Pulmonary Artery Pulsatility As A Predictor Of Survival Following Hospitalized Exacerbation Of Chronic Obstructive Pulmonary Disease
Funder
National Health and Medical Research Council
Funding Amount
$128,224.00
Summary
Many patients with Chronic Obstructive Pulmonary Disease (COPD) also have elevated lung blood pressures, or pulmonary hypertension (PH). Having both conditions increases the risk of death. It is difficult to diagnose PH in COPD. We will be using a new Computed Tomography (X-ray imaging) technique to investigate a marker of PH called ‘pulmonary artery pulsatility’. If PH can be diagnosed easily and accurately new treatments can be devised and researched potentially improving outcomes in COPD.